These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20236133)

  • 1. Donor graft does not affect the P450 2C19 genotype expressed in peripheral blood in recipients of living donor liver transplantation.
    Chiu KW; Tai WC; Nakano T; Tseng HP; Cheng YF; Jawan B; Goto S; Chen CL
    Clin Transplant; 2010; 24(6):830-4. PubMed ID: 20236133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of CYP2C19 genotypes on graft pathological findings and postoperative liver function in recipients after living-donor liver transplantation.
    Chiu KW; Nakano T; Hu TH; Tseng HP; Cheng YF; Jawan B; Eng HL; Goto S; Chen CL
    Ann Transplant; 2010; 15(4):38-43. PubMed ID: 21183874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homogenous phenomenon of graft liver CYP2C19 genotypes after living donor liver transplantation.
    Chiu KW; Nakano T; Hu TH; Tseng HP; Cheng YF; Jawan B; Eng HL; Goto S; Chen CL
    Eur J Clin Invest; 2012 Apr; 42(4):352-6. PubMed ID: 21913914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Western blotting analysis for quantitative detection of CYP2C19 expression in liver tissues in the setting of living donor liver transplantation.
    Chiu KW; Nakano T; Tseng HP; Cheng YF; Jawan B; Eng HL; Goto S; Chen CL
    Hepatogastroenterology; 2012 May; 59(115):805-8. PubMed ID: 22469723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation.
    Uesugi M; Kikuchi M; Shinke H; Omura T; Yonezawa A; Matsubara K; Fujimoto Y; Okamoto S; Kaido T; Uemoto S; Masuda S
    Pharmacogenet Genomics; 2014 Jul; 24(7):356-66. PubMed ID: 24911663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients.
    Hosohata K; Masuda S; Katsura T; Takada Y; Kaido T; Ogura Y; Oike F; Egawa H; Uemoto S; Inui K
    Drug Metab Dispos; 2009 Apr; 37(4):821-6. PubMed ID: 19139162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 in living donor liver transplantation.
    Chiu KW; Nakano T; Chen KD; Hsu LW; Lai CY; Huang CY; Cheng YF; Goto S; Chen CL
    J Biomed Sci; 2015 May; 22(1):32. PubMed ID: 25975271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation from living donors with Gilbert's syndrome is a safe procedure for both donors and recipients.
    Tanoglu A; Artis T; Donmez R; Kargi A; Sit M; Aslan S; Yazar S; Beyazit Y; Polat KY
    Clin Transplant; 2015 Nov; 29(11):965-70. PubMed ID: 26271485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
    Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients.
    Saner FH; Olde Damink SW; Pavlakovic G; van den Broek MA; Rath PM; Sotiropoulos GC; Radtke A; Canbay A; Paul A; Nadalin S; Malagó M; Broelsch CE
    Transplantation; 2008 Jun; 85(11):1564-8. PubMed ID: 18551060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation in the United States: a report from the Organ Procurement and Transplantation Network.
    Smith CM; Davies DB; McBride MA
    Clin Transpl; 2000; ():19-30. PubMed ID: 11512312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
    Ayala R; Grande S; Albizua E; Crooke A; Meneu JC; Moreno A; Pérez B; Gilsanz F; Moreno E; Martínez-Lopez J
    Liver Transpl; 2009 Jun; 15(6):581-91. PubMed ID: 19479801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The travails of setting up a living donor liver transplant program: Experience from Pakistan and lessons learned.
    Dar FS; Bhatti AB; Dogar AW; Zia H; Amin S; Rana A; Nazer R; Khan NA; Khan EU; Rajput MZ; Salih M; Shah NH
    Liver Transpl; 2015 Jul; 21(7):982-90. PubMed ID: 25891412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor hypernatremia before procurement and early outcomes following pediatric liver transplantation.
    Kaseje N; McLin V; Toso C; Poncet A; Wildhaber BE
    Liver Transpl; 2015 Aug; 21(8):1076-81. PubMed ID: 25902852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of liver-transplant candidates for adult-to-adult living donor liver transplantation as the only surgical option for end-stage liver disease.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Omata M; Makuuchi M
    Liver Transpl; 2006 Jul; 12(7):1077-83. PubMed ID: 16598784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hematopoietic stem cell number in the peripheral blood of pediatric recipients correlates with the outcome after living donor liver transplantation.
    Gautier SV; Shevchenko OP; Tsirulnikova OM; Kurabekova RM; Lugovskaya SA; Naumova EV; Tsirulnikova IE; Dolgov VV
    Pediatr Transplant; 2015 Aug; 19(5):531-7. PubMed ID: 25951239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of HLA compatibility in living donor liver transplantation: the double-edged sword associated with the patient outcome.
    Uchiyama H; Kayashima H; Matono R; Shirabe K; Yoshizumi T; Ikegami T; Soejima Y; Matsuura T; Taguchi T; Maehara Y
    Clin Transplant; 2012; 26(5):E522-9. PubMed ID: 23061761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donor liver transplantation for children with liver failure and concurrent multiple organ system failure.
    Mack CL; Ferrario M; Abecassis M; Whitington PF; Superina RA; Alonso EM
    Liver Transpl; 2001 Oct; 7(10):890-5. PubMed ID: 11679988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.